ARTICLE | Product Development
Bruker-Novacyt, PerkinElmer launch COVID-19 diagnostics; plus Nuclein speeds development its PCR test
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
March 25, 2020 1:40 AM UTC
Updated on Apr 4, 2020 at 3:12 AM UTC
New COVID-19 diagnostics were launched in Europe and the U.S. on Tuesday, while another company is speeding up development of an PCR self-test.
Bruker Corp. (NASDAQ:BRKR) announced the European launch of a COVID-19 test from Primerdesign Ltd., a Novacyt S.A. (LSE:NCYT; Euronext:ALNOV) subsidiary. The real-time PCR test from Primerdesign’s genesig platform is to be used in conjunction with the GenoXtract automated genome extraction device and associated kits from Bruker subsidiary Bruker-Hain Diagnostics. Bruker has distribution rights for the PCR test, which has a CE-IVD mark...